S, S., M, A., N, G., R, T., SB, H., S, I., . . . J, v. G. (2025). Sustained inflammation during human T-lymphotropic virus type 1 infection: A wildfire contributing to disease progression. Frontiers in medicine, 12, 1653384. https://doi.org/10.3389/fmed.2025.1653384
Chicago Style (17th ed.) CitationS, Shegefti, Alaei M, Ghahari N, Telittchenko R, Hanafi SB, Isnard S, Routy JP, Olagnier D, and van Grevenynghe J. "Sustained Inflammation During Human T-lymphotropic Virus Type 1 Infection: A Wildfire Contributing to Disease Progression." Frontiers in Medicine 12 (2025): 1653384. https://doi.org/10.3389/fmed.2025.1653384.
MLA (9th ed.) CitationS, Shegefti, et al. "Sustained Inflammation During Human T-lymphotropic Virus Type 1 Infection: A Wildfire Contributing to Disease Progression." Frontiers in Medicine, vol. 12, 2025, p. 1653384, https://doi.org/10.3389/fmed.2025.1653384.